Alzheimer’s drug
Healthcare
FDA Greenlights Eli Lilly’s Alzheimer’s Drug Donanemab
On Tuesday, the Food and Drug Administration (FDA) granted approval for Eli Lilly’s Alzheimer’s drug, donanemab, marking a significant milestone in the treatment...
